# A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread

> **NCT01395121** · PHASE2 · COMPLETED · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 29 (actual)

## Conditions studied

- Mucosal Lentiginous Melanoma
- Acral Lentiginous Malignant Melanoma

## Interventions

- **DRUG:** nilotinib

## Key facts

- **NCT ID:** NCT01395121
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2016-12-12
- **Final completion:** 2016-12-12
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2017-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01395121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01395121, "A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01395121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*